13023_2021_2009_MOESM1_ESM.xlsx (11.96 kB)
Additional file 1 of Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations
dataset
posted on 2021-09-04, 03:24 authored by Sarah E. Wetzel-Strong, Shantel Weinsheimer, Jeffrey Nelson, Ludmila Pawlikowska, Dewi Clark, Mark D. Starr, Yingmiao Liu, Helen Kim, Marie E. Faughnan, Andrew B. Nixon, Douglas A. MarchukAdditional file 1: Table S1. Linear regression of biomarker levels between vascular malformation diseases. CI = confidence interval; PI = proportional increase; Bold values indicate markers with a q-value less than 0.05. Sample sizes vary from 45 to 59 for HHT vs. CCM, 38 to 52 for HHT vs. Sporadic BAVM, and 17 to 27 for CCM vs. Sporadic BAVM.
